
Medicine and Health
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
C. Kim, D. Ryu, et al.
Discover how the CT-P59 monoclonal antibody exhibits strong neutralization against SARS-CoV-2, including the D614G variant, with promising therapeutic effects demonstrated in animal models. This groundbreaking research was conducted by Cheolmin Kim, Dong-Kyun Ryu, Jihun Lee, and fellow authors.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.